Coma - 553 Studies Found

Terminated : A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)
: Chondrosarcoma
: 2007-10-12
: Drug: PRO95780 Intravenous repeating dose
Completed : A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
: Conventional Chondrosarcoma
: 2011-03-03
:
  • Drug: IPI-926 Oral
Completed : Proton Therapy for Chordomas and/or Chondrosarcomas
:
  • Chordomas
  • Chondrosarcomas

: 2008-11-24
Recruiting : Proton Radiation for Chordomas and Chondrosarcomas
:
  • Chordomas
  • Chondrosarcomas

: 2011-10-04
: Radiation: Proton Therapy
Recruiting : Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine
:
  • Chordoma
  • Chondrosarcoma

: 2007-12-28
: Radiation: Charged Particle Radiation Therapy Radiation doses will be determined by planning CT
Active, not recruiting : Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
:
  • Advanced Desmoid Tumor
  • Advanced Chondrosarcoma

: 2009-06-25
: Drug: Imatinib Mesylate 800 mg p.o./day (400 mg b.i.d.) for a maximum of 24 months
Recruiting : Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma
:
  • Solitary Fibrous Tumor
  • Extraskeletal Myxoid Chondrosarcoma

    • : 2014-02-14
    : Drug: Pazopanib Treatment will continue until disease progression, development of unacceptable toxicity,
Active, not recruiting : Vismodegib in Treating Patients With Advanced Chondrosarcomas
:
  • Clear Cell Chondrosarcoma
  • Dedifferentiated
  • Other: Laboratory Biomarker Analysis

Recruiting : Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
:
  • Conventional Chondrosarcoma
  • Myxoid Liposarcoma